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Abstract. Genetic types of plasminogen were determined from a donor and a recip-
ient before and after hepatic homotransplantation. Examination of the plasminogen 
types demonstrated that the liver is the principal site of synthesis of human plasmino-
gen. 
The glycoprotein plasminogen is the 
zymogen form of the proteolytic en-
zyme plasmin (E.C. 3.4.21.7). Plasmin 
functions in degradation of fibrinogen 
and the fibrin blood clot. The site of syn-
thesis of the plasma protein plasminogen 
has been the subject of controversy. Ge-
netic typing of proteins in a liver donor 
and a recipient before hepatic homo-
transplantation and from the recipient af-
ter transplantation has established that 
the liver is the primary site of synthesis 
of haptoglobin, Gc-globulin, orosomu-
coid, transferrin, aI-antitrypsin, and the 
complement proteins, factor B, C3, C6, 
and CS (1). 
Initially, plasminogen was localized 
in the eosinophilic series of granulocytes 
in the bone marrow by immunofluores-
cence (2). In that experiment, no plas-
minogen was detected in surgical biopsy 
specimens of liver, spleen, lymph nodes, 
or lung. This was interpreted to mean 
that plasminogen is synthesized within 
developing and maturing eosinophils of 
the bone marrow. Other investigators 
observed no production of plasminogen 
by the isolated perfused rat liver (3). In 
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addition, plasminogen was detected in 
human granulocytes and monocytes, de-
pending upon the maturation stage (4) . 
The zymogen appeared in promyelo-
cytes, reached highest activity in meta-
myelocytes and in band cells, and then 
gradually decreased during maturation . 
No differences in plasminogen content 
among mature neutrophils, eosinophils, 
and basophils were detected. Plasmino-
gen has also been detected in red blood 
cells (5), although at a low level. 
In contrast, a study of patients with 
abnormal liver functions revealed that 75 
percent had low levels of plasminogen 
(6). In a study with rats, streptokinase 
was injected intravenously to deplete the 
circulating plasminogen (7). After sud-
den depletion, concentration of plasmin 
in the renal vein was twice that in the 
renal artery, while no arteriovenous dif-
ference was detected for the liver. These 
studies did not resolve whether plas-
minogen was synthesized de novo in the 
kidney or activated there . Siefring and 
Olstellino described de novo bios yn-
thesis of plasminogen in the anephric rat 
(8). None of these investigators exam-
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ined the production of plasminogen in 
vivo after homotransplantation , although 
experiments of this type would establish 
the principal site of synthesis of plasma 
proteins. 
We have delineated a common genetic 
polymorphism in human plasminogen by 
treating serum or plasma samples with 
neuraminidase. Genetic differences in 
asialo plasminogens were detected by 
using isoelectric focusing in polyacryl-
amide gel and either immunofixation or 
caseinolytic overlay after urokinase acti-
vation (9). Briefly, serum or plasma sam-
ples (7 ILl) were treated with 10 ILl of 
Clostridium perfringens neuraminidase 
(10 U/ml, pH 6.S) (Sigma, type VI) con-
taining 0.OO5M EDT A. The mixture was 
subjected to constant dialysis against a 
phosphate buffer for 5 hours at room 
temperature. Ampholytes (LKB In-
struments) ranging in pH from 3.5 to 10 
at a final concentration of 2 percent were 
incorporated into 5 percent acrylamide 
gels with 0.2M taurine. Gels were polym-
erized with riboflavin and light. Sam-
ples of the mixture (approximately 15 ILl) 
were applied by moistening small rec-
tangles of Whatman No. I filter paper 
and placing them on the gel surface near 
the anode. Isoelectric focusing was per-
formed for 16 to IS hours at 450 V. After 
isoelectric focusing, the gels were ex-
posed to 1 ml of urokinase at 100 U/ml 
(Calbiochem) and overlaid with a casein-
agarose gel. The overlaid plates were 
then incubated for 2 to 4 hours at 37°C in 
a moist chamber. Plates were fixed in \0 
8 percent trichloroacetic acid for 30 to 60 
seconds and washed overnight in dis-
tilled water. 
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Fig. I (left). Plasminogen types in a donor (D) and recipient (R) before and after renal homo-
transplantation , demonstrated by caseinolytic overlay. From left to right:· donor, recipient be-
fore transplantation, recipient I week after transplantation, and recipient 2 weeks after trans-
plantation. Fig. 2 (right) . Plasminogen types in a donor and recipient before and after liver 
homotransplantation, demonstrated by caseinolytic overlay. From left to right: donor, recipient 
before transplantation , recipient I month after transplantation, and recipient 6 months after 
transplantation. The specimen from the donor was obtained immediately prior to death, and it 
appeared to show reduced plasminogen activit;' at that time. 
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Plasminogen patterns consisting of 
clear proteolyzed areas in a milky casein 
background were immediately discern-
ible. Two common plasminogen alleles, 
PLGN' A and PLGN';'B (10) , have been 
observed in each major race. Several 
rare alleles with isoelectric points more 
acidic than PLGN A or more basic than 
PLGN 8 have also been observed. After 
a plasma sample is treated with neura-
minidase, each allele product resolves 
into two major bands. Mixtures of 
plasma from a person with PLGN A and 
from one with PLGN 8 mimic the pat-
tern produced by PLGN AB plasma. A 
similar polymorphism has been de-
scribed for plasminogen in untreated 
plasma (I J). However, there is ambi-
guity in typing plasminogen in untreated 
plasma. 
Plasminogen types were determined 
in plasma samples from a recipient of 
kidney homotransplantation and from 
his mother, the donor, before trans-
plantation and in two samples from the 
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recipient after transplantation. Figure I 
shows the plasminogen type of the do-
nor, PLGN BBr (rare), and of the re-
cipient, PLGN ABr, before renal trans-
plantation. The Br (B rare) pattern con-
sists of three major bands, two of which 
are shared with the B variant. The recipi-
ent did not lose the two major A bands in 
the 2 weeks after the transplantation. 
Figure 2 shows the plasminogen type ofa 
donor, PLGN A, and of the recipient, 
PLGN B, before hepatic transplantation. 
In plasma samples obtained from the 
recipient after the liver transplant, the 
plasminogen type shows a change to that 
of the donor. 
We conclude that most, ifnot all, plas-
minogen in human plasma is synthesized 
in the liver. These experiments confirm 
that virtually all plasma proteins except 
for the immunoglobulins are synthesized 
by the liver in vivo (/2). 
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